VANGUARD GROUP INC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 116 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 1.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,954,378
-59.2%
2,761,102
-1.2%
0.00%
Q2 2023$7,234,544
-51.8%
2,793,260
-24.1%
0.00%
Q1 2023$15,008,374
-33.4%
3,678,523
-18.1%
0.00%
-100.0%
Q4 2022$22,535,528
-55.8%
4,489,149
+15.1%
0.00%
-50.0%
Q3 2022$51,003,000
+16.9%
3,899,297
+14.6%
0.00%
+100.0%
Q2 2022$43,629,000
-5.1%
3,403,208
+12.9%
0.00%0.0%
Q1 2022$45,971,000
-12.5%
3,014,475
+1.6%
0.00%0.0%
Q4 2021$52,550,000
+60.2%
2,967,237
+90.2%
0.00%0.0%
Q3 2021$32,794,000
+19.7%
1,560,125
+12.3%
0.00%0.0%
Q2 2021$27,392,000
-58.0%
1,389,074
-38.0%
0.00%
-50.0%
Q1 2021$65,160,000
+22.5%
2,241,448
+27.6%
0.00%0.0%
Q4 2020$53,206,000
+131.2%
1,756,261
+21.4%
0.00%
+100.0%
Q3 2020$23,014,000
-17.3%
1,446,537
+2.7%
0.00%0.0%
Q2 2020$27,812,000
+375.8%
1,408,979
+197.2%
0.00%
Q1 2020$5,845,000
-31.2%
474,007
+3.1%
0.00%
Q4 2019$8,500,000
+257.7%
459,709
+168.0%
0.00%
Q3 2019$2,376,000
-3.3%
171,544
+2.2%
0.00%
Q2 2019$2,457,000167,8490.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Column Group LLC 16,245,817$247,749,00045.93%
Ponoi II Management, LLC 1,298,908$19,808,00043.96%
RHO CAPITAL PARTNERS INC 3,766,666$57,442,00039.74%
Ponoi Management, LLC 1,298,908$19,808,00025.71%
Euclidean Capital LLC 746,674$11,387,0006.62%
StepStone Group LP 1,573,357$23,994,0001.79%
SILVERARC CAPITAL MANAGEMENT, LLC 200,494$3,058,0001.26%
First Light Asset Management, LLC 816,653$12,454,0001.10%
BVF INC/IL 955,000$14,564,0000.58%
HighVista Strategies LLC 46,243$705,0000.45%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders